International Circulation

Interview with Prof. Athena Poppas: Women's cardiovascular disease in the treatment and research need to pay attention to things

NIRS-IVUS can help identify plaques that easily cause clinical events and improve outcomes

Mavacamten: a dawn to hypertrophic cardiomyopathy

Blood pressure medication should be viewed as an effective tool for reducing cardiovascular risk

The results of the LoDoCo2 trial establish colchicine as a potential new option for long-term prevention of CV events in patients with chronic coronary disease